QUANTITATION OF SUBSTANCE-P AND ITS METABOLITES IN PLASMA AND SYNOVIAL-FLUID FROM PATIENTS WITH ARTHRITIS

被引:32
作者
JOYCE, TJ
YOOD, RA
CARRAWAY, RE
机构
[1] UNIV MASSACHUSETTS, SCH MED, DEPT PHYSIOL, 55 LAKE AVE N, WORCESTER, MA 01655 USA
[2] FALLON CLIN INC, DIV RHEUMATOL, WORCESTER, MA 01604 USA
[3] ST VINCENTS HOSP, WORCESTER, MA 01604 USA
关键词
D O I
10.1210/jc.77.3.632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substance-P (SP) and its metabolites, SP-(1-7) and SP-(5-11), were quantitated in arthritic synovial fluids and plasmas using a validated procedure. This process involved collection into appropriate enzyme inhibitors, extraction with acid-acetone, high pressure liquid chromatography, and RIA using region-specific antisera. Our results demonstrate that the levels of authentic SP in these fluids are less than 3.5 pmol/L, which is 50- to 10,000-fold less than those previously reported by others. These discrepant findings were not attributable to degradation, because added SP was recovered in good yield, and the measured levels of the metabolites SP-(1-7) and SP-(5-11) were also extremely low. In search of an explanation, we noted that many of the earlier reports involved direct assay of these fluids (without extraction and chromatography). Further work indicated that proteolytic enzymes (eg. protease 24.11) present in these unextracted fluids can give rise to artifactually high SP measurements. We conclude that if SP is released within the joint space and if it participates in the inflammatory reaction and/or healing process, it most likely does so in a local fashion, which would not involve its accumulation in synovial fluid or plasma
引用
收藏
页码:632 / 637
页数:6
相关论文
共 45 条
[1]   ARE LYMPHOCYTES A TARGET FOR SUBSTANCE-P MODULATION IN ARTHRITIS [J].
AGRO, A ;
STANISZ, AM .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (04) :252-258
[2]   ENKEPHALINASE - A PHYSIOLOGICAL NEUROIMMUNOMODULATOR DETECTED IN THE SYNOVIAL-FLUID [J].
APPELBOOM, T ;
DEMAERTELAER, V ;
DEPREZ, E ;
HAUZEUR, JP ;
DESCHODTLANCKMAN, M .
ARTHRITIS AND RHEUMATISM, 1991, 34 (08) :1048-1051
[3]  
BALFE A, 1983, P INT S, P169
[4]  
BALFE A, 1984, THESIS DUBLIN U COLL
[5]   AXONAL-TRANSPORT OF SUBSTANCE-P IN THE VAGUS AND SCIATIC-NERVES OF THE GUINEA-PIG [J].
BRIMIJOIN, S ;
LUNDBERG, JM ;
BRODIN, E ;
HOKFELT, T ;
NILSSON, G .
BRAIN RESEARCH, 1980, 191 (02) :443-457
[6]   DIFFERENCE IN BEHAVIOR BETWEEN SYNTHETIC AND ENDOGENOUS SUBSTANCE-P IN HUMAN-PLASMA [J].
CANNON, DEB ;
SKRABANEK, P ;
POWELL, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 307 (03) :251-255
[7]  
CHAPMAN LF, 1980, FED PROC, V39, P603
[8]   CONVERSION OF SUBSTANCE-P TO C-TERMINAL FRAGMENTS IN HUMAN-PLASMA [J].
CONLON, JM ;
SHEEHAN, L .
REGULATORY PEPTIDES, 1983, 7 (04) :335-345
[9]   THE BINDING OF ENDOGENOUS AND EXOGENOUS SUBSTANCE-P IN HUMAN PLASMA [J].
CORBALLY, N ;
POWELL, D ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (07) :1161-1166
[10]  
COSTA M, 1985, SUBSTANCE P METABOLI, P99